Back to top
more

Addus HomeCare (ADUS)

(Delayed Data from NSDQ)

$94.54 USD

94.54
205,950

+2.84 (3.10%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $94.49 -0.05 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

St. Jude Medical: Proclaim Elite SCS System Now CE Marked

St. Jude Medical Inc. (STJ), a leading global medical device manufacturer recently announced the CE mark approval for the full-body magnetic resonance (MR) conditional labeling of the Proclaim Elite Spinal Cord Stimulation (SCS) System.

    Merit Medical Hits 52-Week High: What's Driving the Stock?

    Share price of South Jordan, Utah-based Merit Medical Systems, Inc. (MMSI) reached a fresh 52-week high of $26.80 on Dec 9, finally closing a tad lower at $26.60.

      West Pharma (WST) Hits 52-Week High on Growth Prospects

      Shares of West Pharmaceutical Services, Inc. (WST) reached a new 52-week high of $84.21 on Friday, Dec 9, 2016.

        The Cooper Companies (COO) Beats Q4 Earnings Estimates

        The Cooper Companies Inc. (COO) reported adjusted earnings of $2.28 in fourth-quarter 2016, surpassing the Zacks Consensus Estimate by 4 cents and improving 14% on a year-over-year basis.

          Integer (ITGR) to Co-Develop CCM Therapy with Impulse Dynamics

          Integer Holdings Corporation (ITGR) announced that it has signed a development agreement with Impulse Dynamics.

            Ecolab (ECL) Rewards Shareholders with 6% Dividend Hike

            Ecolab Inc. (ECL) declared a quarterly cash dividend of 37 cents per share, reflecting a 6% increase from the previous payout.

              ABIOMED Impella CP Gets Expanded FDA Approval, Stock Up

              Danvers, MA-based ABIOMED, Inc. (ABMD), a leading medical product developer, announced the expanded U.S. FDA pre-market approval (PMA) for the usage of Impella CP heart pump.

                Top Ranked Momentum Stocks to Buy for December 8th

                Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, December 8th:

                  Inogen (INGN) Affirms Outlook and Shuffles Top Management

                  Inogen, Inc. (INGN) reiterated its fiscal 2016 outlook and appointed a new President cum Chief Executive Officer.

                    CryoLife (CRY) Now a Strong Buy: Should You Add the Stock?

                    On Dec 6, Kennesaw, GA-based CryoLife Inc. (CRY) was raised to a Zacks Rank #1 (Strong Buy).

                      athenahealth-ADP Launch Cloud-Based Payroll for Hospitals

                      athenahealth Inc (ATHN) recently introduced cloud-based payroll and attendance services for small hospitals in collaboration with Automatic Data Processing (ADP).

                        Luminex Awarded R&D 100 for ARIES Systems in November

                        Luminex Corporation (LMNX) announced that its ARIES Systems was awarded the R&D 100 Award at the 54th Annual R&D 100 Awards ceremony in November.

                          Allscripts Buys Core Medical Solutions, Expands in Australia

                          Allscripts Healthcare Solutions, Inc. (MDRX), a leading global provider of information technology and services to healthcare organizations, recently announced the acquisition of Core Medical Solutions to expand its offerings in Australia.

                            Envision Healthcare Ties Up with Alabama Neonatal Medicine

                            Envision Healthcare Corporation (EVHC) announced the acquisition of Alabama Neonatal Medicine, P.C. and the extension of its Women's and Children's Services specialty.

                              Top Ranked Momentum Stocks to Buy for December 6th

                              Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, December 6th:

                                DaVita Ties Up With Inspira Health, Expands in South Jersey

                                DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services in the U.S., announced a joint venture with Inspira Health Network to expand dialysis services at the Bridgeton, Millville and Vineland centers of South Jersey.

                                  Top Ranked Momentum Stocks to Buy for November 28th

                                  Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, November 28th:

                                    Top Ranked Momentum Stocks to Buy for November 18th

                                    Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, November 18th:

                                      Addus HomeCare, Monster Beverage, ConocoPhillips and Diamondback Energy as Zacks Bull and Bear of the Day

                                      Addus HomeCare, Monster Beverage, ConocoPhillips and Diamondback Energy as Zacks Bull and Bear of the Day

                                        Kevin Cook headshot

                                        Bull of the Day: Addus HomeCare (ADUS)

                                        Big earnings beat and solid guidance lift estimates for next year by 20%

                                          Top Ranked Momentum Stocks to Buy for November 16th

                                          Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, November 16th:

                                            Top Ranked Momentum Stocks to Buy for November 14th

                                            Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, November 14th:

                                              Kevin Matras headshot

                                              Your Next Stock Should Be Making New Highs

                                              This week, Kevin Matras talks about stocks making new highs and why you shouldn't be afraid to buy them. Highlighted stocks include ADUS, AMWD, BLMN, MGA and OMG.

                                                Kevin Matras headshot

                                                Addus HomeCare (ADUS)

                                                See how the Zacks Rank can quickly spot stocks trading under their fair value with the highest probability of going up.